SCHEMBL25567708

SCHEMBL25567708

COc1ccc(Cn2nc(I)c3c2CCC3)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.47
STAT3 P40763 1/20 0.44
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 2/20 0.43
PTGS2 P35354 2/20 0.42
HTR6 P50406 1/20 0.42
PTGIR P43119 1/20 0.42
FABP4 P15090 1/20 0.41
PTGS1 P23219 1/20 0.41
BLM P54132 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16731504 0.83 SMN1; SMN2 (0.43) SMN1; SMN2STAT3ALDH1A1MEN1KMT2A
SCHEMBL25255613 0.82 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1MEN1KMT2AMAPT
SCHEMBL25567711 0.82 SMN1; SMN2 (0.44) SMN1; SMN2STAT3ALDH1A1MEN1KMT2A
SCHEMBL1894478 0.81 PTGS2 (0.44) SMN1; SMN2STAT3ALDH1A1MEN1KMT2A
SCHEMBL1006441 0.80 SMN1; SMN2 (0.44) SMN1; SMN2STAT3ALDH1A1MEN1KMT2A
SCHEMBL16731505 0.79 SMN1; SMN2 (0.44) SMN1; SMN2STAT3PTGS2HTR6PTGIR
SCHEMBL31329856 0.73 CNR1 (0.42) SMN1; SMN2ALDH1A1MEN1KMT2AMAPT
SCHEMBL25567709 0.73 CNR1 (0.42) SMN1; SMN2ALDH1A1MEN1KMT2AMAPT
SCHEMBL18019749 0.72 RORC (0.45) SMN1; SMN2ALDH1A1KMT2AMAPTL3MBTL1
SCHEMBL16731507 0.72 BUB1 (0.47) STAT3PTGS2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250026762-A1 FUSED PYRAZOLE UREA ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-01-23 US disclosed
WO-2023101895-A1 FUSED PYRAZOLE UREA ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS MERCK SHARP & DOHME LLC (US) 2023-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026762-A1 FUSED PYRAZOLE UREA ANALOGS AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GBA1, GBA2, UGCG SMN1; SMN2 1330/4885STAT3 4699/4885ALDH1A1 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.